Hangzhou Binjiang Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HANGZHOU BINJIANG, and what generic and branded alternatives to HANGZHOU BINJIANG drugs are available?
HANGZHOU BINJIANG has four approved drugs.
Drugs and US Patents for Hangzhou Binjiang
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hangzhou Binjiang | TADALAFIL | tadalafil | TABLET;ORAL | 208824-002 | Oct 27, 2020 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hangzhou Binjiang | TADALAFIL | tadalafil | TABLET;ORAL | 208824-001 | Oct 27, 2020 | AB1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hangzhou Binjiang | METHOCARBAMOL | methocarbamol | TABLET;ORAL | 200958-001 | Oct 21, 2011 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hangzhou Binjiang | RISEDRONATE SODIUM | risedronate sodium | TABLET;ORAL | 207516-001 | Feb 15, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Hangzhou Binjiang | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 090258-002 | Sep 24, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hangzhou Binjiang | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 090258-003 | Sep 24, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Hangzhou Binjiang | ALENDRONATE SODIUM | alendronate sodium | TABLET;ORAL | 090258-004 | Sep 24, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.